Locked nucleic acid modified DNA enzymes targeting early growth response-1 inhibit human vascular smooth muscle cell growth.
about
In vitro selection, characterization, and application of deoxyribozymes that cleave RNADual specificity phosphatase 15 regulates Erk activation in Schwann cellsLocked nucleoside analogues expand the potential of DNAzymes to cleave structured RNA targetsEfficient inhibition of HIV-1 expression by LNA modified antisense oligonucleotides and DNAzymes targeted to functionally selected binding sites.Chemical synthesis of LNA-2-thiouridine and its influence on stability and selectivity of oligonucleotide binding to RNA.Chlamydia pneumoniae infection promotes a proliferative phenotype in the vasculature through Egr-1 activation in vitro and in vivo.Egr-1 expression during neointimal development in flow-associated pulmonary hypertension.Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.The role of mPer1 in morphine dependence in miceDNAzymes and cardiovascular disease.Deoxyribozymes and bioinformatics: complementary tools to investigate axon regeneration.DNA Catalysis: The Chemical Repertoire of DNAzymes.A critical role for Egr-1 during vascular remodelling in pulmonary arterial hypertension.Suppression of vascular permeability and inflammation by targeting of the transcription factor c-Jun.Inhibition of Egr1 expression underlies the anti-mitogenic effects of cAMP in vascular smooth muscle cells.DNA enzyme ED5 depletes egr-1 and inhibits neointimal hyperplasia in rats.The advantages of being locked. Assessing the cleavage of short and long RNAs by locked nucleic acid-containing 8-17 deoxyribozymes.Suppression of inducible nitric oxide synthase by 10-23 DNAzymes in murine macrophage.
P2860
Q24817034-D527C390-CD7B-4146-AF2F-4F2CCA49BD97Q29976914-596DED97-606C-4C85-9166-FAFB23865B7AQ33245746-7B9434D9-B850-41C9-B720-6282CED6DD11Q33282788-E136A349-8DFC-48A2-BC94-6D57C41AAC72Q33730176-09D4FDDF-3D7C-41A2-B82E-BDBAE555CDCAQ33927267-ED25816B-C92F-4EBE-B3C6-AAEA9579F1E3Q34021089-CE9F8AEC-BAFB-495F-AC14-5CD669FA78BAQ36918516-D8349B88-DFF5-42A5-B708-EF9705A3B436Q37130244-CC4469F1-9B58-4B61-9742-8BA48AE371A3Q37153589-AB8EECA8-FBBA-4057-AD96-26E453AF355DQ37970644-F3EF924E-AFCF-493F-AAF5-CD0E0CA3A9A0Q38648771-766AD66B-CC81-4DC2-A328-DF018D841EEBQ39159352-96534C2B-7DC5-4B4D-A76A-7E479A2507F4Q40258486-24CDE669-34F8-4BFC-B75D-BE438D2DE0F9Q40529249-73CB5DF1-4D22-499C-9022-D072BFBB8AA2Q50901167-9184DE2B-EB94-41CC-B157-56A62767E5AEQ52582539-98C376B8-3A76-44E1-A94B-DF08F7DB13AEQ53631801-4CC0743F-0DF4-4948-94FA-2379C1978832
P2860
Locked nucleic acid modified DNA enzymes targeting early growth response-1 inhibit human vascular smooth muscle cell growth.
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Locked nucleic acid modified D ...... lar smooth muscle cell growth.
@ast
Locked nucleic acid modified D ...... lar smooth muscle cell growth.
@en
type
label
Locked nucleic acid modified D ...... lar smooth muscle cell growth.
@ast
Locked nucleic acid modified D ...... lar smooth muscle cell growth.
@en
prefLabel
Locked nucleic acid modified D ...... lar smooth muscle cell growth.
@ast
Locked nucleic acid modified D ...... lar smooth muscle cell growth.
@en
P2860
P356
P1476
Locked nucleic acid modified D ...... lar smooth muscle cell growth.
@en
P2093
Levon M Khachigian
Roger G Fahmy
P2860
P304
P356
10.1093/NAR/GKH543
P407
P577
2004-04-23T00:00:00Z